Devashish Chowdhury

Devashish Chowdhury

About

Detail

Head of Marketing
Maharashtra, India

Timeline


work
Job
school
Education
folder
Project

Résumé


Jobs verified_user 0% verified
  • QuidelOrtho
    Head of Marketing
    QuidelOrtho
    Nov 2022 - Dec 2025 (3 years 2 months)
    Led commercial marketing for a ₹900–1,100 Cr diagnostics portfolio across India & South Asia, supporting over 50% of ASPAC revenue. In an increasingly competitive market and following the revised UCMPMD guidelines, I helped reposition marketing from an event-driven function to a strategic commercial growth partner by building compliant, high-value stakeholder engagement across the healthcare ecosystem. Commercial Impact • Delivered 30%+ growth across strategic portfolios and increased analyzer installations by 20%+ through customer-centric commercialization and strategic account engagement. • Redesigned customer engagement under the revised UCMPMD framework by shifting to hospital-based programs, city-level scientific interactions and c
  • Rivaara Labs
    Commercial Director
    Rivaara Labs
    Jul 2020 - Oct 2022 (2 years 4 months)
    Joined the molecular diagnostics start-up to build its commercial foundation from the ground up. Designed the go-to-market strategy, commercial model and customer engagement framework, enabling rapid scale-up across multiple cities during one of the most dynamic phases of India's diagnostics industry. Commercial Impact • Scaled the business from ₹0 to ₹40+ Cr within 24 months, expanding operations across 15 cities through a scalable commercial growth strategy. • Built the commercial organization, including GTM strategy, pricing architecture, channel partnerships, sales processes, CRM governance and forecasting systems to support sustainable growth. • Established strategic partnerships with hospitals, laboratories and clinicians, accelerat
  • A
    Marketing Manager
    Abbott Healthcare
    Jun 2019 - Jun 2020 (1 year 1 month)
    Led commercialization of Abbott's Point-of-Care diagnostics portfolio across India, helping expand adoption of decentralized testing in critical care settings. Partnered with commercial and regional teams to position diagnostics closer to the patient, improving clinical workflows and supporting faster decision-making in Emergency Departments and Intensive Care Units. Commercial Impact • Managed a ₹75–100 Cr Point-of-Care diagnostics portfolio, driving commercial strategy across critical care and emergency medicine. • Conceptualized the "Uberization of Blood Gas Testing" initiative, promoting decentralized testing by bringing diagnostics closer to the point of care and improving workflow efficiency. • Increased adoption of Point-of-Care Bl
  • Medikabazaar
    Vice President Operations
    Medikabazaar
    Feb 2018 - Jun 2019 (1 year 5 months)
    Led the commercialization of innovative oncology technologies by building market access, clinical adoption and strategic partnerships for advanced surgical solutions. Worked closely with clinicians, hospitals and global technology partners to introduce new treatment modalities into the Indian healthcare ecosystem. Commercial Impact • Led the commercial strategy for HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and HIVEC (Hyperthermic Intravesical Chemotherapy) technologies, helping establish new treatment pathways in Surgical Oncology and Uro-Oncology. • Built strategic relationships with surgical oncologists, urologists, hospital management and procurement teams to accelerate adoption of high-value medical technologies. • Introduced
  • Ortho Clinical Diagnostics
    Marketing Lead - Clinical Laboratories (India & South Asia)
    Ortho Clinical Diagnostics
    Feb 2015 - Apr 2017 (2 years 3 months)
    Appointed to lead the Marketing function during the transition of Ortho Clinical Diagnostics from Johnson & Johnson to The Carlyle Group. Partnered closely with regional and global leadership to preserve customer confidence, strengthen brand equity and sustain commercial momentum during a period of significant organizational change. Represented India on the Global Marketing Council, contributing regional market insights to global portfolio and commercialization strategy. Commercial Impact • Successfully protected customer trust during the ownership transition by executing an intensive customer engagement strategy, retaining over 99% of the installed customer base while ensuring uninterrupted commercial continuity. • Developed and executed
  • K
    Country Manager - India & South Asia
    Kedrion Biopharma
    Feb 2013 - Jan 2015 (2 years)
    Established Kedrion's commercial presence in India by building the business from the ground up. Led market entry, commercial strategy, regulatory coordination and customer engagement for a specialty plasma therapeutics portfolio, creating the foundation for sustainable growth in a highly regulated healthcare environment. Commercial Impact • Built the complete commercial infrastructure for the India business, integrating market access, sales, marketing, distribution, regulatory and supply chain into a scalable operating model. • Led full ₹55–60 Cr P&L responsibility, balancing commercial growth with financial discipline in a highly specialized therapeutic market. • Achieved EBITDA-positive performance by Year 2, while expanding government
  • J
    Business Manager
    Johnson Johnson Medical India JJMI Ltd
    Dec 2001 - Jan 2013 (11 years 2 months)
    Spent over a decade building commercial leadership across sales, key account management, commercial excellence and business management. Working with world's most respected diagnostics companies, I learned that sustainable commercial growth is created through customer trust, strategic relationships and disciplined execution—not products alone. Over this period, I partnered with laboratory leaders, clinicians, hospital administrators and channel partners to expand market share, strengthen institutional relationships and accelerate adoption across India's diagnostics landscape. Commercial Impact • Expanded the diagnostics business from ₹35 Cr to ₹100 Cr, driving sustained growth through strategic account development, value-based selling an
  • Wipro
    Area Sales Manager
    Wipro
    Apr 1998 - Nov 2001 (3 years 8 months)
    Reported to the Regional Business Head and managed two assistants as well as distributors of ophthalmology, orthopedic & general surgery products; established sales objectives and actionable plans for sub territories, and projected expected sales volume and profit for existing and new products ►Maintained sales volumes, product mix, and selling price by keeping current with supply and demand, changing trends, economic indicators & competitors ►Prepared the business plan for ophthalmology products, introduced the products and achieved business plan for consecutive years. ►Built the channel for low-end products & worked with top customers for high-end Excimer Laser systems. ►Maintained knowledge by attending educational workshops, reviewin
  • I
    Sales Executive
    Ing Tech Engineering Co
    Jan 1996 - Jan 1998 (2 years 1 month)
  • Ion Exchange India Ltd
    Project Officer
    Ion Exchange India Ltd
    Jan 1993 - Jan 1996 (3 years 1 month)
Education verified_user 0% verified
  • K
    Bachelor of Engineering (BE, Chemical Engineering
    KES Engineering College
  • Welingkar Institute of Management
    MMM, Marketing Management
    Welingkar Institute of Management
    Jan 1995 - Jan 1998 (3 years 1 month)
  • S
    Sri Vani Vidya Sala High School
    Sri Vani Vidya Sala High School
    Jan 1975 - Jan 1984 (9 years 1 month)
Projects (professional or personal) verified_user 0% verified
  • C
    CME in a Box
    Jun 2011 - Dec 2012 (1 year 7 months)
    This was a low cost high impact Touch program. Defined program objectives, contents, number of participants. Prepared standard invites, standees, standard presentations. The idea was to connect with 4-6 clinicians at a neutral venue to discuss @ Anti-D prophylaxis. Objective was to connect to 1500 Clinicians & 3000 Nurses
  • C
    Costing Tool for Biochemistry analyser decision
    Apr 2008 - Mar 2011 (3 years)
    Dry Chemistry machines were perceived 70-100% expensive than traditional systems. Customers generally compared the consumable cost & took decisions. I prepared a cost simulator to compare various competitive models of Biochemistry analyzer with Dry chemistry analyzer. The simulator was on Total Operating Cost. It was a hit as we closed at least 30 accounts (50+ analyzers) in 2 years. This generated big value accounts & gave customers an opportunity to audit their costs.
  • D
    DT ReVital
    Apr 2008 - Mar 2010 (2 years)
    As Focus moved to automation in Biochemistry, the attention to 500+ desktop user was going down. The project was to engage DT users strongly. The result was consumable business grew by 21% than PY & @ 25 customers migrated to automation, adding to healthy top line & contribution
Awards verified_user 0% verified
  • J
    Awarded stock options available for high performers & Ranked 8 on performance rating of 9
    Jan
  • D
    East India - Fastest growing consumable business
    DEC
  • J
    Value Award for best Financial performance
    Jan
  • J
    Awarded stock options available for high performers & Ranked 8 on performance rating of 9
    Jan
  • D
    Special recognition for RhoGAM business from Global group
    DEC
This is a community-created genome.